Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC
| dc.contributor.author | Sanz Sánchez, Tatiana | |
| dc.contributor.author | Giménez Arnau, Ana María | |
| dc.contributor.author | Zaragoza Ninet, Violeta | |
| dc.contributor.author | Córdoba Guijarro, Susana | |
| dc.contributor.author | Miquel Miquel, Francisco Javier | |
| dc.contributor.author | Silvestre Salvador, Juan Francisco | |
| dc.contributor.author | González Pérez, Ricardo | |
| dc.contributor.author | Ruiz González, Inmaculada | |
| dc.contributor.author | Mercader García, Pedro | |
| dc.contributor.author | Serra Baldrich, Esther | |
| dc.contributor.author | Et.al. | |
| dc.date.accessioned | 2026-01-27T08:24:39Z | |
| dc.date.available | 2026-01-27T08:24:39Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | 2-Bromo-2-nitro-propane-1,3-diol (bronopol) is a formaldehyde releaser that was included as an emerging allergen needing to be evaluated in the European series in 2019, and as a candidate allergen for inclusion in the Spanish baseline series based on data from the Spanish Registry for Research in Dermatitis and Contact Allergy (REIDAC), in TRUE Test 0.25 mg/cm2 or 0.5% pet. in 2022. In a previous Spanish study, we perceived a frequency of sensitization to bronopol of 0.36% (15/4088) and we noted that the TRUE Test detected 13 of 15 overall reactions to bronopol. We found a current relevance of 6/13 in TRUE Test and none in petrolatum. However, one limitation of this work was that the data could not be directly compared because they came from different populations. The present study was then designed within REIDAC due to differences, with the aim of updating epidemological data regarding sensitizations to bronopol and evaluating discordant patch test reactions to bronopol. | |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 4.6 Q1 JCR 2024 | spa |
| dc.description.impact | 0.981 Q1 SJR 2024 | spa |
| dc.description.impact | No data IDR 2024 | spa |
| dc.description.sponsorship | Fundación Piel Sana | |
| dc.description.sponsorship | Spanish Agency for Medicines and Health Products | |
| dc.description.sponsorship | Sanofi and LeoPharma | |
| dc.identifier.citation | Sánchez, T. S., Giménez‐Arnau, A. M., Ninet, V. Z., Guijarro, S. C., Miquel, F. J. M., Salvador, J. F. S., Pérez, R. G., González, I. R., Mercader‐García, P., Baldrich, E. S., Carrillo, J. M. C., Romero, F. T., De Frutos, F. J. O., Serna, M. R., Ortega, M. E. G., Suárez, C. P., Navarro‐Triviño, F., Chicharro, P., Nieto, M. A. P., … Borrego, L. (2025). Discordant patch test reactions to 2‐bromo‐2‐nitro‐propane‐1,3‐diol (Bronopol): A multicenter study from reidac. Contact Dermatitis, cod.70082. https://doi.org/10.1111/cod.70082 | |
| dc.identifier.doi | 10.1111/cod.70082 | |
| dc.identifier.issn | 0105-1873 | |
| dc.identifier.issn | 1600-0536 | |
| dc.identifier.uri | https://hdl.handle.net/11268/16765 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1111/cod.70082 | |
| dc.rights.accessRights | restricted access | |
| dc.subject.other | Dermatitits | |
| dc.subject.other | Formaldehído | |
| dc.subject.other | Erupciones por Medicamentos | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Químico farmacéutico | |
| dc.subject.unesco | Enfermedad de la piel | |
| dc.subject.unesco | Investigación médica | |
| dc.title | Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Discordant Patch Test_2026.pdf
- Size:
- 201.56 KB
- Format:
- Adobe Portable Document Format

